109 related articles for article (PubMed ID: 25268101)
1. A novel screening test for colon cancer: Talin-1.
Bostanci O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Mihmanli M
Eur Rev Med Pharmacol Sci; 2014; 18(17):2533-7. PubMed ID: 25268101
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin-M as a novel biomarker in colon cancer patients and its association with clinicopathologic variables.
Gurluler E; Tumay LV; Guner OS; Kucukmetin NT; Hizli B; Zorluoglu A
Eur Rev Med Pharmacol Sci; 2014; 18(14):2042-7. PubMed ID: 25027345
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
4. Decreased preoperative serum fibulin-3 levels in colon cancer patients.
Simsek O; Kocael A; Kemik A; Vatankulu B; Kocael P; Halac M; Ulualp K; Sonmezoglu K
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4076-80. PubMed ID: 26592829
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Pang L; Wang DW; Zhang N; Xu DH; Meng XW
Cancer Biomark; 2016 Mar; 16(4):599-607. PubMed ID: 27002762
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.
Mashaly AH; Anwar R; Ebrahim MA; Eissa LA; El Shishtawy MM
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1503-1508. PubMed ID: 29936723
[TBL] [Abstract][Full Text] [Related]
7. Discovery and validation of new potential biomarkers for early detection of colon cancer.
Solé X; Crous-Bou M; Cordero D; Olivares D; Guinó E; Sanz-Pamplona R; Rodriguez-Moranta F; Sanjuan X; de Oca J; Salazar R; Moreno V
PLoS One; 2014; 9(9):e106748. PubMed ID: 25215506
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients.
Giaginis C; Margeli A; Kouraklis G; Zira A; Tsourouflis G; Theocharis S
Int J Biol Markers; 2009; 24(2):70-6. PubMed ID: 19634109
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum levels of mesothelin in patients with colon cancer.
Bostancı O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Yavuz A; Mihmanlı M
Dis Markers; 2014; 2014():161954. PubMed ID: 25477701
[TBL] [Abstract][Full Text] [Related]
10. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.
Shao S; Neely BA; Kao TC; Eckhaus J; Bourgeois J; Brooks J; Jones EE; Drake RR; Zhu K
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):711-718. PubMed ID: 28003179
[No Abstract] [Full Text] [Related]
13. Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.
Klupp F; Neumann L; Kahlert C; Diers J; Halama N; Franz C; Schmidt T; Koch M; Weitz J; Schneider M; Ulrich A
BMC Cancer; 2016 Jul; 16():494. PubMed ID: 27431388
[TBL] [Abstract][Full Text] [Related]
14. Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.
Aydin MA; Gul G; Kiziltan R; Algul S; Kemik O
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10512-10517. PubMed ID: 33155206
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity.
Muto M; Mori M; Liu J; Uzawa A; Uchida T; Masuda H; Ohtani R; Sugimoto K; Kuwabara S
J Neuroimmunol; 2017 Apr; 305():131-134. PubMed ID: 28284333
[TBL] [Abstract][Full Text] [Related]
16. [Serum adipokines and their receptors in endometrial and colon cancer patients: relationship with tumor invasion and metastasis].
Yunusova NV; Kondakova IV; Kolomiets LA; S G Afanasiev ; Chernyshova AL; Shatokhina OV; Frolova AE; Zhou Z; Wang W
Vopr Onkol; 2015; 61(4):619-23. PubMed ID: 26571833
[TBL] [Abstract][Full Text] [Related]
17. Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver.
Zuo Y; Ren S; Wang M; Liu B; Yang J; Kuai X; Lin C; Zhao D; Tang L; He F
Gut; 2013 Aug; 62(8):1169-78. PubMed ID: 22637699
[TBL] [Abstract][Full Text] [Related]
18. Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma.
Okugawa Y; Miki C; Toiyama Y; Koike Y; Inoue Y; Kusunoki M
Dis Colon Rectum; 2009 Jul; 52(7):1330-6. PubMed ID: 19571712
[TBL] [Abstract][Full Text] [Related]
19. Talin-1 and Non-invasive Fibrosis Models in the Assessment of Patients with Hepatocellular Carcinoma.
Alsebaey A; Ahmedy EA
Asian Pac J Cancer Prev; 2016; 17(8):4077-82. PubMed ID: 27644664
[TBL] [Abstract][Full Text] [Related]
20. Identification of cripto-1 as a novel serologic marker for breast and colon cancer.
Bianco C; Strizzi L; Mancino M; Rehman A; Hamada S; Watanabe K; De Luca A; Jones B; Balogh G; Russo J; Mailo D; Palaia R; D'Aiuto G; Botti G; Perrone F; Salomon DS; Normanno N
Clin Cancer Res; 2006 Sep; 12(17):5158-64. PubMed ID: 16951234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
